NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

My understanding is that the P&L statement always provides gross revenue, not net revenue. Is this case different because it's under R&D revenue? If so that is definitely news to me and it's very important to understand that correctly. I've written to DI for clarification on this.

WRT your explanation on the billing profile, indeed that is a very important point because if we are thinking that the total cost to the patient would be say $220k USD and would imagine that they get billed all at once upfront then $880k would represent only 4 patients. If in fact, some or most patients treated this quarter have only been billed so far for creating the lysate and will end up being billed most of the total charges only as they receive the injections over the course of X months, then they probably treated a lot more than 4 patients, though we don't have any idea how many patients were actually treated which would be an important number to understand.